Jolanta Kunikowska

Learn More
PURPOSE Peptide receptor radionuclide therapy (PRRT) using radiolabelled somatostatin analogues is a treatment option for patients with disseminated neuroendocrine tumours (NET). A combination treatment using the high-energy 90Y beta emitter for larger lesions and the lower energy 177Lu for smaller lesions has been postulated in the literature.The aim of(More)
PURPOSE Prior studies have suggested that (18)F-FDG PET/CT can help characterize adrenal lesions and differentiate adrenal metastases from benign lesions. The aim of this study was to assess the value of (18)F-FDG PET/CT for the differentiation of malignant from benign adrenal lesions. METHODS This retrospective study included 85 patients (47 men and 38(More)
Contrast-enhanced computed tomography (CECT) and positron emission tomography with 18-FDG (FDG-PET/CT) are used to identify malignant solitary pulmonary nodules. The aim of the study was to evaluate the accuracy of CECT and FDG-PET/CT in diagnosing the etiology of solitary pulmonary nodule (SPN). Eighty patients with newly diagnosed SPN >8 mm were enrolled.(More)
12 13 14 PREAMBLE 15 16 The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of 17 Nuclear Medicine (EANM) have written and approved guidelines to promote the use of nuclear 18 medicine procedures with high quality. These guidelines are intended to assist practitioners in 19 providing appropriate nuclear medicine care(More)
  • 1